Therapy News and Research

RSS

Patients affected by depression more likely to stop taking their heart medications

Patients who feel low when having a cardiac device implanted are more likely to stop taking their heart medications than those without depression, according to research presented today at ACNAP 2023, a scientific congress of the European Society of Cardiology.

25 Jun 2023

New category of depression identified

Scientists at Stanford Medicine conducted a study describing a new category of depression - labeled the cognitive biotype - which accounts for 27% of depressed patients and is not effectively treated by commonly prescribed antidepressants.

23 Jun 2023

Eliminating cancer cell repopulation may be the key to curing cancer

A new research perspective was published in Oncoscience (Volume 10) on June 1, 2023, entitled, "Cancer cell repopulation after therapy: which is the mechanism?"

23 Jun 2023

UVA Health researcher launches an ambitious effort to improve HIV care

A UVA Health doctor is launching an ambitious effort to assess and improve HIV care for people with low incomes across the nation, a campaign that could also help prevent transmission.

23 Jun 2023

Research sheds light on how steroids affect cancer Immunotherapy

Immunotherapy is among the newest and most potent weapons against cancer. It prompts the immune system to recognize tumors as intruders in the body and attack. But not all patients respond well to immunotherapy. Why? Scientists aren't always sure.

23 Jun 2023

New study offers hope for women suffering from axillary web syndrome

Axillary web syndrome, also known as lymphatic thrombus, is a complication in the clinical manifestations suffered by many women after overcoming breast cancer, mainly affecting their shoulder mobility.

23 Jun 2023

New project aims to improve the efficacy and safety of CAR T therapies for solid tumors

Partners in the international consortium CAR T-REX announce the awarding of a highly competitive EIC Pathfinder Open grant, following the positive evaluation of their project entitled 'CAR T Cells Rewired to Prevent EXhaustion in the Tumour Microenvironment'.

23 Jun 2023

The use of bacterial colonists as therapy carriers is gaining interest for treating cancer

Study describes the use of engineered commensal bacteria to increase antitumor immunity.

23 Jun 2023

Prior exposure to air pollutants and black carbon load predicts outcomes in hospitalized COVID-19 patients

Researchers investigated whether black carbon particles in the blood increased COVID-19 severity.

23 Jun 2023

Prevalence study uncovers rising threat: enterovirus D68 and acute flaccid myelitis link

Study evaluated the changes in the transmission of EV-D68 in England inferred from seroprevalence data.

23 Jun 2023

Cell and gene therapy CDMO Andelyn Biosciences celebrates over 20 years of leadership and innovation with opening of new 180,000 square foot manufacturing headquarters

Andelyn Biosciences, a pioneer in the development and manufacturing of cell and gene therapies, today formally inaugurates its new manufacturing headquarters, the Andelyn Corporate Center (ACC), located in the Innovation District in Columbus, Ohio.

From Andelyn Biosciences 23 Jun 2023

Study finds the risk of recurrence of active disease in older patients with MS after discontinuing therapy

An article published today in the journal Lancet Neurology evaluates the risk of recurrence of active disease in older patients with multiple sclerosis after discontinuing disease-modifying therapies.

23 Jun 2023

Viral clearance: A potential predictor of COVID-19 treatment efficacy

Researchers determine the virological effects of COVID-19 treatment and its clinical efficacy in the same trial.

22 Jun 2023

Omega-3 fatty acids linked to lower atrial fibrillation risk in U.S. veterans

Researchers determine whether marine omega-3 fatty acid consumption increases atrial fibrillation risk among United States military veterans.

22 Jun 2023

New standard more effective at preventing graft-versus-host disease

Clinicians have a new standard for graft-versus-host disease (GVHD) prevention after allogeneic hematopoietic stem cell transplantation, according to results from a phase III study published June 22 in the New England Journal of Medicine.

22 Jun 2023

Study finds new way to predict therapy response in metastatic renal cell carcinoma

Dr. Niklas Klümper, resident at the Department of Urology and Pediatric Urology of the University Hospital Bonn (UKB) and working group leader at the Institute for Experimental Oncology (IEO), and Dr. Jonas Saal, resident at the Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology of the UKB, demonstrated a significant improvement in predicting the response to therapy in metastatic renal cell carcinoma by incorporating the level of inflammation, which was assessed using two straightforward blood parameters, alongside the conventional imaging-based approach.

22 Jun 2023

World's largest gathering of NF community convenes in Arizona to advance research and care

From June 21 through June 27, the largest gathering of NF researchers, clinicians, and patients in the world will take place at the Fairmont Scottsdale Princess in Scottsdale, Arizona.

22 Jun 2023

New platform technology bridges the gap between microscopic analysis and multiplex imaging

Researchers at the Ludwig Center at Harvard have developed a platform technology for imaging that enables integration of the methods of microscopic analysis long employed in pathology laboratories with the visualization of multiple molecular markers in individual cells that is now rapidly advancing in research labs.

22 Jun 2023

MD Anderson and Ochsner Health join forces to advance cancer care in Louisiana

The University of Texas MD Anderson Cancer Center and New Orleans-based Ochsner Health today announced a partnership to create Ochsner MD Anderson Cancer Center in southeastern Louisiana.

22 Jun 2023

First successful Phase 2 trial uses cutting-edge RNA CAR-T therapy to treat autoimmunity

Cartesian Therapeutics, a clinical-stage biotechnology company pioneering cell therapies for autoimmune diseases, announced today the publication of a landmark paper in The Lancet Neurology.

22 Jun 2023

Therapy News and Research

Patients affected by depression more likely to stop taking their heart medications

New category of depression identified

Eliminating cancer cell repopulation may be the key to curing cancer

UVA Health researcher launches an ambitious effort to improve HIV care

Research sheds light on how steroids affect cancer Immunotherapy

New study offers hope for women suffering from axillary web syndrome

New project aims to improve the efficacy and safety of CAR T therapies for solid tumors

The use of bacterial colonists as therapy carriers is gaining interest for treating cancer

Prior exposure to air pollutants and black carbon load predicts outcomes in hospitalized COVID-19 patients

Prevalence study uncovers rising threat: enterovirus D68 and acute flaccid myelitis link

Cell and gene therapy CDMO Andelyn Biosciences celebrates over 20 years of leadership and innovation with opening of new 180,000 square foot manufacturing headquarters

Study finds the risk of recurrence of active disease in older patients with MS after discontinuing therapy

Viral clearance: A potential predictor of COVID-19 treatment efficacy

Omega-3 fatty acids linked to lower atrial fibrillation risk in U.S. veterans

New standard more effective at preventing graft-versus-host disease

Study finds new way to predict therapy response in metastatic renal cell carcinoma

World's largest gathering of NF community convenes in Arizona to advance research and care

New platform technology bridges the gap between microscopic analysis and multiplex imaging

MD Anderson and Ochsner Health join forces to advance cancer care in Louisiana

First successful Phase 2 trial uses cutting-edge RNA CAR-T therapy to treat autoimmunity

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News